Browse All

Current Filters

CLEAR FILTER x

TITLE

Week 96 Analysis of the OCARINA II Study Characterizing Subcutaneous Ocrelizumab in Patients With Relapsing or Primary Progressive Multiple Sclerosis

Author:Newsome, Scott D.   Goldstick, Lawrence   Selmaj, Krzysztof   Krzystanek, Ewa   Zecevic, Dusanka   Clinch, Susanne   Giacobino, Caroline   Azmi, Jay   Figueiredo, Catarina   Centonze, Diego   

Session Name:P7: Multiple Sclerosis: Clinical Trials 1  

Topic:Multiple Sclerosis  

Program Number:P7.006  

Author Institution:Johns Hopkins University School of Medicine, Baltimore, MD, USA, Baltimore, MD  Department of Neurology and Rehabilitation Waddell Center for Multiple Sclerosis, University of Cincinnati, College of Medicine, Cincinnati, OH, USA, Dayton, OH  Centrum Neurologii, Lódz, Poland and Department of Neurology, University of Warmia & Mazury, Olsztyn, Poland, Poland  Department of Neurology, School of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland, Katowice, Poland  F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland  Roche Products Ltd, Welwyn Garden City, UK, United Kingdom  Department of Systems Medicine, Tor Vergata University, Rome, Italy and Unit of Neurology, IRCCS Neuromed, Pozzilli (IS), Italy, Italy